Effect of cold rolling on the magnetic susceptibility of Zr–14Nb alloy

The magnetic susceptibility of cold-rolled Zr–14Nb was evaluated to apply a new metallic medical device used for magnetic resonance imaging (MRI). The magnetic susceptibility of cold-rolled Zr–14Nb decreased up to the reduction ratio of 30%, then gradually decreased up to the ratio of 90%. Transmiss...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta biomaterialia 2013-03, Vol.9 (3), p.5795-5801
Hauptverfasser: Kondo, Ryota, Shimizu, Ryota, Nomura, Naoyuki, Doi, Hisashi, Suyalatu, Tsutsumi, Yusuke, Mitsuishi, Kazutaka, Shimojo, Masayuki, Noda, Kazuhiko, Hanawa, Takao
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The magnetic susceptibility of cold-rolled Zr–14Nb was evaluated to apply a new metallic medical device used for magnetic resonance imaging (MRI). The magnetic susceptibility of cold-rolled Zr–14Nb decreased up to the reduction ratio of 30%, then gradually decreased up to the ratio of 90%. Transmission electron microscopic observation revealed the strain-induced formation of ω phase after cold rolling at the reduction ratio of 5%, indicating that the initial decrease in magnetic susceptibility was caused by the formation of the ω phase. The ω phase was saturated at the reduction ratio of 30%. The formation of the ω phase could be explained on the basis of the increase in the Young’s modulus and Vickers hardness of cold-rolled Zr–14Nb. The effect of texture formation on these properties was not obvious in the cold-rolled Zr–14Nb. Because of the strain-induced formation of the ω phase, the magnetic susceptibility of Zr–14Nb can be reduced by cold rolling to as low as that of as-cast Zr–9Nb, which is one-third that of Ti and Ti alloys. Therefore, cold-workable Zr–14Nb with low magnetic susceptibility could be a promising alloy for medical devices under MRI.
ISSN:1742-7061
1878-7568
DOI:10.1016/j.actbio.2012.10.046